Thus, one compound (4s) that is structurally simpler than other available SMO antagonists on the market showed the highest cytotoxic effect (IC50 of 1.3–15 μM) in all tumour cell lines and was equally effective in both HH-dependent and independent cell lines assayed. Here, SMO is linked to neoplasm.